Cyndeo Wealth Partners »

Heron Therapeutics shares owned by Cyndeo Wealth Partners

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Cyndeo Wealth Partners from 13F filings

Historical chart of Cyndeo Wealth Partners investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Cyndeo Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Cyndeo Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $313k 248k 1.26
2025-06-30 $514k 248k 2.07

More positions owned by Cyndeo Wealth Partners

Microsoft Corporation (MSFT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Oracle Corporation (ORCL)
Meta Platforms Cl A (META)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl A (GOOGL)
Abbott Laboratories (ABT)
First Tr Exchange Trad Fd Vi FST TR GLB FD (FTGC)
Vanguard Index Fds Small Cp Etf (VB)
First Tr Exchange-traded Core Investment (FTCB)

View all positions for Cyndeo Wealth Partners

Top funds holding Heron Therapeutics

Rubric Capital Management
Adage Capital Partners GP
BlackRock
Clearline Capital
Velan Capital Investment Management
Vanguard Group
Palisade Capital Management
Tejara Capital
Baker Bros. Advisors
State Street Corporation
Geode Capital Management
Tang Capital Management
JW Asset Management
D. E. Shaw & Co
UBS Group

View all funds holding Heron Therapeutics